A topical prostaglandin for glaucoma.
D000287:Administration, Topical; D018663:Adrenergic Agents / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D018678:Cholinergic Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D004837:Epinephrine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D015337:Multicenter Studies as Topic; D010277:Parasympathomimetics / Q000008:administration & dosage; D010862:Pilocarpine / Q000008:administration & dosage; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D013999:Timolol / Q000627:therapeutic use
D018663:Adrenergic Agents; D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D018678:Cholinergic Agents; D010277:Parasympathomimetics; D011461:Prostaglandins F, Synthetic; D010862:Pilocarpine; D000077338:Latanoprost; D013999:Timolol; C015173:dipivefrin; D004837:Epinephrine